Helicobacter Pylori Seropositivity in Patients with Postmenopausal Osteoporosis

DOI Web Site 被引用文献2件 参考文献49件
  • Akkaya Nuray
    Department of Physical Medicine and Rehabilitation, Pamukkale University, Medical School
  • Akkaya Semih
    Department of Orthopedics and Traumatology, Pamukkale University Medical School
  • Polat Yusuf
    Denizli Clinical Microbiology, Government Hospital
  • Turk Meral
    Denizli Clinical Parasitology, Government Hospital
  • Turk Tufan
    Denizli Clinic of Rheumatology, Government Hospital
  • Ergur Sadik
    Denizli Clinical of Nucleer Medicine, Government Hospital
  • Sahin Fusun
    Department of Physical Medicine and Rehabilitation, Pamukkale University, Medical School

この論文をさがす

抄録

[Purpose] The results of studies investigating the role of Helicobacter pylori (HP) in osteoporosis are contradictory. In this study we investigated HP seropositivity in postmenopausal osteoporotic and non-osteoporotic females to elucidate the role of HP in postmenopausal osteoporosis. [Subjects and Methods] Serum was collected from fifty-eight osteoporotic patients and forty-seven nonosteoporotic subjects, whose status was diagnosed with dual-energy X-ray absorptiometry (DEXA). None of the subjects had received any prior treatment for osteoporosis. Subjects' sera were assessed for HP antibodies (Immunoglobulin A and G) by enzyme-linked immunoabsorbent assay (ELISA). Patients were interviewed about risk factors of osteoporosis. Prior fractures of patients and familial fracture history were also noted. [Results] Fifty-eight patients with osteoporosis and forty-seven nonosteoporotic patients, as determined by lumbar total or collum femoris in DEXA, were evaluated in this study. The familial fracture history was significantly higher in the osteoporotic patients than in the nonosteoporotic group. There was no significant difference in HP seropositivity between the osteoporotic and nonosteoporotic groups. [Conclusion] There was no difference in HP seropositivity between the groups, therefore HP infection seems not to be an important risk factor for postmenopausal osteoporosis.<br>

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (49)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ